[1]
Tanveer, M., Verma, N., Singh, S., Narayan, J., Kumar, P. and Ahmad, E. 2024. Effect of Novel Biomarkers like Asprosin, Visfatin, and Subfatin in Cases of Metabolic Syndrome: A Systematic Review. Hypertension Journal. 10, 2 (Jul. 2024), 51–55. DOI:https://doi.org/10.61081/htnj/24v10i205.